Curio Wellness Establishes Cockeysville, Maryland, Medical Cannabis Facility
12/10/2021
According to company officials, the 34,000 square-foot building will allow Curio to scale up production, keeping pace with the state’s rapidly growing medical cannabis industry while continuing its focus on research and development of targeted cannabis-based therapeutics.
“As the hub of production for our cGMP and award-winning products, the opening of our new product innovation site plays a significant role in furthering our mission to provide the accessibility of therapeutic medicinal cannabis solutions to patients across the state and beyond,” said Wendy Bronfein, co-founder, chief brand officer and director of public policy at Curio Wellness. “With this new facility, we look forward to maximizing our efforts in providing people with safe, effective and reliable products, while reaffirming our dedication to bringing a positive and tangible impact to Maryland’s economy.”
The facility’s role will be to produce the company’s quality medicinal cannabis products including Medicated Chews, Good Night, and Vape lines, as well as licensed products by Dixie, Wana, Kaviar and Mary’s Medicinals, exclusive to Curio Wellness. It will also serve as the home to production innovation and a research laboratory, furthering the company’s focus on targeted, scientifically developed medicinal products derived from cannabis.
Project Announcements
Germany-Based Sennheiser Group Plans Nashville, Tennessee, Operations
03/12/2026
Interstate Group Expands Giles County, Virginia, Production Operations
03/11/2026
Shinhwa Auto USA Expands Auburn, Alabama, Operations
03/11/2026
General Atomics Expands Shannon, Mississippi, Production Operations
03/11/2026
Starbucks Plans Davidson County, Tennessee, Corporate Operations
03/08/2026
Canada-Based Dainty Foods Plans Batavia Township, Ohio, Manufacturing Operations
03/08/2026
Most Read
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024
-
What Companies Need from Modern Manufacturing Sites
Q1 2026
-
Preparing for the Next USMCA Shake-Up
Q4 2025
-
Economic Developer Role Shifting from Deal-Making to Systems Stewardship
Q1 2026
-
The New Industrial Revolution in Biotech
Q4 2025
-
Capitalizing on the OBBBA Before the 2026 Cliff
Q1 2026
-
The Skilled Trades Are Ready for a Digital Future
Q4 2025